Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress

Biomedicine and Pharmacotherapy

Volumn 88, Issue , 2017, Pages 1025-1030

  El Bassossy, Hany M ^a,b   Ghaleb, Hanna ^a   Elberry, Ahmed A ^c   Balamash, Khadijah S ^a   Ghareib, Salah A ^a,c   Azhar, Ahmad ^d   Banjar, Zainy ^d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Zagazig University   (Egypt)

^c BENI SUEF UNIVERSITY   (Egypt)

^d King Abdulaziz University   (Saudi Arabia)

Author keywords

Cardioprotective; Cardiovascular complications; Diabetes; Electrocardiogram; Geraniol; Heart; Hemodynamics

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; CATALASE; CHOLESTEROL; GERANIOL; GLUCOSE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; 8-EPI-PROSTAGLANDIN F2ALPHA; GLUCOSE BLOOD LEVEL; PROSTAGLANDIN F2 ALPHA; TERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CATHETER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DRUG ACTIVITY; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; HEART VENTRICLE PRESSURE; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QTC INTERVAL; RAT; SYSTOLE; T WAVE; TRIACYLGLYCEROL BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; COMPLICATION; DIABETES COMPLICATIONS; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEMODYNAMICS; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES COMPLICATIONS; DINOPROST; ELECTROCARDIOGRAPHY; HEMODYNAMICS; MALE; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; RATS, WISTAR; TERPENES;

EID: 85011588281     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.01.131     Document Type: Article

References (43)

1. [1] Østergaard, J., Hansen, T.K., Thiel, S., Flyvbjerg, A., Complement activation and diabetic vascular complications. Clin. Chim. Acta 361:1 (2005), 10–19.
2. [2] Marzona, I., Avanzini, F., Lucisano, G., Tettamanti, M., Baviera, M., Nicolucci, A., et al. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the risk and prevention study. Acta Diabetol., 2016, 1–9.
3. [3] Hayat, S.A., Patel, B., Khattar, R.S., Malik, R.A., Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin. Sci. 107:6 (2004), 539–557.
4. [4] Fang, Z.Y., Prins, J.B., Marwick, T.H., Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25:4 (2004), 543–567.
5. [5] Sharma, V., McNeill, J.H., Verma, S., Diabetic cardiomyopathy: where are we 40 years later?. Can. J. Cardiol. 22:4 (2006), 305–308.
6. [6] Goyal, B., Mehta, A., Diabetic cardiomyopathy Pathophysiological mechanisms and cardiac dysfuntion. Hum. Exp. Toxicol. 32:6 (2013), 571–590.
7. [7] Liu, Y.-m., Wang, X., Nawaz, A., Kong, Z.-h., Hong, Y., Wang, C.-h., et al. Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Acta Pharmacol. Sin. 32:12 (2011), 1475–1482.
8. [8] Papa, G., Degano, C., Iurato, M.P., Licciardello, C., Maiorana, R., Finocchiaro, C., Macrovascular complication phenotypes in type 2 diabetic patients. Cardiovasc. Diabetol., 12(1), 2013, 1.
9. [9] Altan, V.M., The pharmacology of diabetic complications. Curr. Med. Chem. 10:15 (2003), 1317–1327.
10. [10] El-Bassossy, H.M., Fahmy, A., Badawy, D., Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem. Toxicol. 49:11 (2011), 3007–3012.
11. [11] Srivastava, Y., Venkatakrishna-Bhatt, H., Verma, Y., Venkaiah, K., Raval, B., Antidiabetic and adaptogenic properties of Momordica charantia extract: an experimental and clinical evaluation. Phytother. Res. 7:4 (1993), 285–289.
12. [12] Liu, J., Zhang, W., Du, G., Chen, J., Zhou, J., Overproduction of geraniol by enhanced precursor supply in Saccharomyces cerevisiae. J. Biotechnol. 168:4 (2013), 446–451.
13. [13] Vinothkumar, V., Manoharan, S., Sindhu, G., Nirmal, M.R., Vetrichelvi, V., Geraniol modulates cell proliferation, apoptosis, inflammation, and angiogenesis during 7, 12-dimethylbenz a anthracene-induced hamster buccal pouch carcinogenesis. Mol. Cell. Biochem. 369:1–2 (2012), 17–25.
14. [14] Brosky, G., Logothetopoulos, J., Streptozotocin diabetes in the mouse and guinea pig. Diabetes 18:9 (1969), 606–611.
15. [15] Ghareib, S.A., El-Bassossy, H.M., Elberry, A.A., Azhar, A., Watson, M.L., Banjar, Z.M., 6-Gingerol alleviates exaggerated vasoconstriction in diabetic rat aorta through direct vasodilation and nitric oxide generation. Drug Des. Dev. Ther., 9, 2015, 6019.
16. [16] El-Bassossy, H.M., Desoky, N., Fahmy, A., Protein kinase C plays an important role in exaggerated vasoconstriction associated with insulin deficiency but not resistance. Proc. Natl. Acad. Sci. India Section B: Biol. Sci. 85:3 (2015), 807–814.
17. [17] Hassan, N.A., El-Bassossy, H.M., Mahmoud, M.F., Fahmy, A., Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness. Chem. Biol. Interact. 213 (2014), 28–36.
18. [18] Aebi, H., Catalase in vitro. Packer, L., Orlando, F.L., (eds.) Methods in Enzymology, 105, 1984, Academic Press, New York, 121–126.
19. [19] Sun, Y., Oberley, L.W., Li, Y., A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988), 497–500.
20. [20] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
21. [21] El-Bassossy, H.M., Elberry, A.A., Ghareib, S.A., Azhar, A., Banjar, Z.M., Watson, M.L., Cardioprotection by 6-gingerol in diabetic rats. Biochem. Biophys. Res. Commun. 477:4 (2016), 908–914.
22. [22] Bellavere, F., Ferri, M., Guarini, L., Bax, G., Piccoli, A., Cardone, C., et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?. Br. Heart J. 59:3 (1988), 379–383.
23. [23] Ewing, D., Boland, O., Neilson, J., Cho, C., Clarke, B., Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 34:3 (1991), 182–185.
24. [24] Tokatli, A., Kiliçaslan, F., Alis, M., Yiginer, O., Uzun, M., Prolonged tp-e interval, tp-e/QT ratio and tp-e/QTc ratio in patients with type 2 diabetes mellitus. Endocrinol. Metab. 31:1 (2016), 105–112.
25. [25] Sawicki, P., Kiwitt, S., Bender, R., Berger, M., The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J. Intern. Med. 243:1 (1998), 49–56.
26. [26] Naas, A.A., Davidson, N.C., Thompson, C., Cummings, F., Ogston, S.A., Jung, R.T., et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. Bmj 316:7133 (1998), 745–746.
27. [27] Magyar, J., Rusznak, Z., Szentesi, P., Szucs, G., Kovacs, L., Action potentials and potassium currents in rat ventricular muscle during experimental diabetes. J. Mol. Cell. Cardiol. 24:8 (1992), 841–853.
28. [28] Shimoni, Y., Firek, L., Severson, D., Giles, W., Short-term diabetes alters K+ currents in rat ventricular myocytes. Circ. Res. 74:4 (1994), 620–628.
29. [29] El-Bassossy, H.M., Elberry, A.A., Ghareib, S.A., Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect. J. Diabetes Complications 30:6 (2016), 1008–1016.
30. [30] El-Bassossy, H.M., Dsokey, N., Fahmy, A., Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome. Toxicol. Mech. Methods 24:8 (2014), 536–543.
31. [31] El-Bassossy, H., Badawy, D., Neamatallah, T., Fahmy, A., Ferulic acid, a natural polyphenol, alleviates insulin resistance and hypertension in fructose fed rats: effect on endothelial-dependent relaxation. Chem. Biol. Interact. 254 (2016), 191–197.
32. [32] Badawy, D., El-Bassossy, H.M., Fahmy, A., Azhar, A., Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity. Can. J. Physiol. Pharmacol. 91:2 (2013), 101–107.
33. [33] Fukai, T., Ushio-Fukai, M., Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signaling 15:6 (2011), 1583–1606.
34. [34] Halliwell, B., Gutteridge, J.M., Free Radicals in Biology and Medicine. 2015, Oxford University Press, USA.
35. [35] Soubh, A.A., Abdallah, D.M., El-Abhar, H.S., Geraniol ameliorates TNBS-induced colitis: involvement of Wnt/β-catenin, p38MAPK, NFκB, and PPARγ signaling pathways. Life Sci. 136 (2015), 142–150.
36. [36] Ibrahim, S.M., El-Denshary, E.S., Geraniol, Abdallah D.M., alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status. PLoS One, 10(2), 2015, e0117516.
37. [37] Daniel, M.J., Lipid management in patients with type 2 diabetes. Am. Health Drug Benefits, 4(5), 2011, 312.
38. [38] Mooradian, A.D., Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Pract. Endocrinol. Metab. 5:3 (2009), 150–159.
39. [39] Robins, S.J., Rubins, H.B., Faas, F.H., Schaefer, E.J., Elam, M.B., Anderson, J.W., et al. Insulin resistance and cardiovascular events with low HDL cholesterol the veterans affairs HDL intervention trial (VA-HIT). Diabetes Care 26:5 (2003), 1513–1517.
40. [40] Crespo, R., Montero Villegas, S., Abba, M.C., de Bravo, M.G., Polo, M.P., Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways. Biochem. Cell Biol. 91:3 (2012), 131–139.
41. [41] Polo, M., Crespo, R., Bravo, Md, Geraniol and simvastatin show a synergistic effect on a human hepatocarcinoma cell line. Cell Biochem. Funct. 29:6 (2011), 452–458.
42. [42] Polo, M.P., De Bravo, M.G., Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2. Biochem. Cell Biol. 84:1 (2006), 102–111.
43. [43] Galle, M., Kladniew, B.R., Castro, M.A., Villegas, S.M., Lacunza, E., Polo, M., et al. Modulation by geraniol of gene expression involved in lipid metabolism leading to a reduction of serum-cholesterol and triglyceride levels. Phytomedicine 22:7 (2015), 696–704.